These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 20338919)
1. Therapeutic conundrum: AIDS therapies may be double-edged swords. Clifford DB Neurology; 2010 Apr; 74(16):1248-9. PubMed ID: 20338919 [No Abstract] [Full Text] [Related]
2. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Robertson KR; Su Z; Margolis DM; Krambrink A; Havlir DV; Evans S; Skiest DJ; Neurology; 2010 Apr; 74(16):1260-6. PubMed ID: 20237308 [TBL] [Abstract][Full Text] [Related]
3. Dementia and neurocognitive disorders due to HIV-1 infection. Ances BM; Ellis RJ Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745 [TBL] [Abstract][Full Text] [Related]
4. [HIV associated encephalopathy after highly active antiretroviral therapy (HAART)]. Kishida S No To Shinkei; 2004 Apr; 56(4):301-10. PubMed ID: 15237721 [No Abstract] [Full Text] [Related]
5. An emerging severe leukoencephalopathy: is it due to HIV disease or highly active antiretroviral therapy? Rackstraw S; Meadway J; Bingham J; Al-Sarraj S; Everall I Int J STD AIDS; 2006 Mar; 17(3):205-7. PubMed ID: 16510013 [TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus encephalopathy: cognitive and radiologic improvement after antiretroviral therapy. Silva MT; Wagner S; Grinsztejn B Arch Neurol; 2009 Aug; 66(8):1040-1. PubMed ID: 19667231 [No Abstract] [Full Text] [Related]
7. Neuropathology and neurodegeneration in HIV infection. Jellinger KA Clin Neuropathol; 2001; 20(6):276-7. PubMed ID: 11758784 [No Abstract] [Full Text] [Related]
9. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine. van Gorp WG; Hinkin CH Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716 [No Abstract] [Full Text] [Related]
10. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. Gray F; Bazille C; Adle-Biassette H; Mikol J; Moulignier A; Scaravilli F J Neurovirol; 2005; 11 Suppl 3():16-22. PubMed ID: 16540449 [TBL] [Abstract][Full Text] [Related]
11. [Psychiatric diseases and HIV infection. These patients are dually stigmatized]. Arendt G; Haslinger BA MMW Fortschr Med; 2003 Apr; 145 Spec No 1():70-2. PubMed ID: 15011597 [TBL] [Abstract][Full Text] [Related]
12. [Neurologic complications of HIV infection in the HAART era. Rapid and efficient diagnosis]. Arendt G; Haslinger BA MMW Fortschr Med; 2003 Apr; 145 Spec No 1():66-9. PubMed ID: 15011596 [TBL] [Abstract][Full Text] [Related]
13. Increase of C1q biosynthesis in brain microglia and macrophages during lentivirus infection in the rhesus macaque is sensitive to antiretroviral treatment with 6-chloro-2',3'-dideoxyguanosine. Depboylu C; Schäfer MK; Schwaeble WJ; Reinhart TA; Maeda H; Mitsuya H; Damadzic R; Rausch DM; Eiden LE; Weihe E Neurobiol Dis; 2005 Oct; 20(1):12-26. PubMed ID: 16137563 [TBL] [Abstract][Full Text] [Related]
14. Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Cook JE; Dasgupta S; Middaugh LD; Terry EC; Gorry PR; Wesselingh SL; Tyor WR Ann Neurol; 2005 Jun; 57(6):795-803. PubMed ID: 15852478 [TBL] [Abstract][Full Text] [Related]
15. Retroviral rebound syndrome with fatal outcome after discontinuation of antiretroviral therapy. Garlin AB; Sax PE Clin Infect Dis; 2005 Nov; 41(9):e83-5. PubMed ID: 16206091 [TBL] [Abstract][Full Text] [Related]
16. Twenty-five years of AIDS: where are we now? Wainberg MA MedGenMed; 2006 Oct; 8(4):21. PubMed ID: 17415304 [No Abstract] [Full Text] [Related]